IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CIMAZ, ROLANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.038
AS - Asia 12.556
EU - Europa 10.143
SA - Sud America 2.605
AF - Africa 390
OC - Oceania 176
Continente sconosciuto - Info sul continente non disponibili 12
Totale 40.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.228
CN - Cina 3.921
SG - Singapore 3.319
GB - Regno Unito 2.043
BR - Brasile 1.827
IT - Italia 1.704
HK - Hong Kong 1.476
RU - Federazione Russa 1.389
DE - Germania 837
IE - Irlanda 817
IN - India 640
JP - Giappone 631
VN - Vietnam 619
SE - Svezia 580
FR - Francia 554
TR - Turchia 466
CA - Canada 444
ID - Indonesia 433
ES - Italia 413
MX - Messico 307
AR - Argentina 287
NL - Olanda 245
KR - Corea 210
BE - Belgio 175
PL - Polonia 167
AU - Australia 163
FI - Finlandia 152
CO - Colombia 147
DK - Danimarca 128
UA - Ucraina 126
GR - Grecia 125
CL - Cile 118
TW - Taiwan 117
PT - Portogallo 99
CH - Svizzera 91
SA - Arabia Saudita 90
AT - Austria 88
TH - Thailandia 87
EC - Ecuador 84
BD - Bangladesh 77
CZ - Repubblica Ceca 75
ZA - Sudafrica 74
EG - Egitto 70
NO - Norvegia 63
RO - Romania 62
IQ - Iraq 61
PE - Perù 58
PH - Filippine 54
IL - Israele 50
MA - Marocco 50
IR - Iran 46
DZ - Algeria 42
EU - Europa 42
PK - Pakistan 34
TN - Tunisia 31
SI - Slovenia 30
VE - Venezuela 29
CI - Costa d'Avorio 27
HU - Ungheria 27
UZ - Uzbekistan 27
HR - Croazia 26
MY - Malesia 24
LY - Libia 23
SK - Slovacchia (Repubblica Slovacca) 22
AE - Emirati Arabi Uniti 21
JO - Giordania 20
RS - Serbia 20
UY - Uruguay 20
KZ - Kazakistan 19
PY - Paraguay 18
AZ - Azerbaigian 17
KE - Kenya 17
NP - Nepal 15
LT - Lituania 14
CR - Costa Rica 13
NZ - Nuova Zelanda 12
BY - Bielorussia 11
BG - Bulgaria 10
BO - Bolivia 10
ET - Etiopia 9
MD - Moldavia 9
OM - Oman 9
SN - Senegal 9
KG - Kirghizistan 8
LB - Libano 8
GT - Guatemala 7
IS - Islanda 7
SY - Repubblica araba siriana 7
BA - Bosnia-Erzegovina 6
BF - Burkina Faso 6
EE - Estonia 6
JM - Giamaica 6
KW - Kuwait 6
LV - Lettonia 6
MO - Macao, regione amministrativa speciale della Cina 6
SR - Suriname 6
XK - ???statistics.table.value.countryCode.XK??? 6
AL - Albania 5
AM - Armenia 5
BH - Bahrain 5
Totale 40.850
Salva come PNG Salva come JPEG
Città #
Singapore 1.683
Southend 1.503
Fairfield 1.430
Ashburn 1.222
Hong Kong 1.125
Princeton 871
Dublin 808
Seattle 754
Wilmington 725
Woodbridge 702
Beijing 662
Dallas 569
Houston 567
Chandler 509
Cambridge 501
Milan 501
Council Bluffs 495
Redwood City 464
Des Moines 325
Ann Arbor 315
Jakarta 288
Los Angeles 286
Buffalo 269
Bengaluru 258
Central District 255
Moscow 250
Santa Clara 215
Ho Chi Minh City 201
Guangzhou 184
Tokyo 180
São Paulo 174
Jinan 163
Shanghai 162
Dearborn 143
Nanjing 140
Cangzhou 133
Phoenix 131
Toronto 126
Hanoi 122
Frankfurt am Main 120
New York 120
Istanbul 113
Chicago 112
Shenyang 109
London 108
Rome 108
Nuremberg 106
Hangzhou 104
San Diego 101
Hefei 96
Columbus 94
Ankara 93
Paris 90
Athens 80
Buenos Aires 78
Berlin 75
Madrid 74
Tianjin 72
Zhengzhou 67
Florence 65
Changsha 63
Guadalajara 60
Helsinki 60
Jacksonville 60
Santiago 60
Seoul 60
Taipei 60
Chengdu 55
Munich 55
Hebei 54
Belo Horizonte 53
Bangkok 52
Wuhan 52
Barcelona 51
Redmond 51
Boardman 50
Ottawa 50
Rio de Janeiro 50
The Dalles 49
Silver Spring 48
Bogotá 47
Vienna 46
Shenzhen 45
Amsterdam 44
Atlanta 44
Lima 44
Mountain View 44
Dong Ket 43
Nanchang 43
Riyadh 41
Taiyuan 41
Hyderabad 40
Grafing 39
Redondo Beach 38
Kunming 37
Medellín 37
Montreal 37
Curitiba 36
Heverlee 36
Prague 36
Totale 23.307
Salva come PNG Salva come JPEG
Nome #
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 2.413
Current and emerging biologics for the treatment of juvenile idiopathic arthritis 1.781
Blau syndrome : cross-sectional data from a multicentre study of clinical, radiological and functional outcomes 878
The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease : a retrospective cases series 655
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's) : an ARChiVe Cohort Study 485
Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic 452
Current evidence of methotrexate efficacy in childhood chronic uveitis : a systematic review and meta-analysis approach 422
Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis 331
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 323
Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis 316
Adalimumab in the treatment of immune-mediated diseases 308
Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated with Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities 290
Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus 268
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases : focus on adalimumab 261
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review 260
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis : 1-year followup data from the Italian Registry 254
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 250
COVID-19 infection and rheumatoid arthritis: Faraway, so close! 250
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 249
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis 244
Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies 239
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome 234
Registries in rheumatological and musculoskeletal conditions : Paediatric Behçet's disease: an international cohort study of 110 patients : one-year follow-up data 218
Anti-inflammatory and immunosuppressive drugs and reproduction 218
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 213
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases 210
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs 209
Gut microbiota in children and altered profiles in juvenile idiopathic arthritis 207
Early joint replacement in juvenile idiopathic arthritis (JIA): trend over time and factors influencing implant survival 193
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors 192
Canakinumab for Childhood Sight-threatening Refractory Uveitis : a Case Series 192
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects 185
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 185
Th17 cells that undergo plasticity to a Th1 phenotype in human autoimmune arthritis can be detected by the expression of CD161 within the inflamed joint 182
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation 180
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in juvenile dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation collaborative initiative 168
Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy 168
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study 166
Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis : report of a family with multiple anti-phospholipid positive members 166
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 164
Methotrexate in juvenile idiopathic arthritis : advice and recommendations from the MARAJIA expert consensus meeting 162
COVID-19 and what pediatric rheumatologists should know: A review from a highly affected country 158
Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis 157
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis : associations with HLA-B27 Allele and Disease Status 157
Is cervical spine involvement in juvenile polyarthritis under-recognized? 157
Systemic-onset juvenile idiopathic arthritis : the changing life of a rare disease 156
Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero 154
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 154
Distinctive features of classic and non-classic (Th17-derived) human Th1 cells 153
Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings 153
Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis : results of a 10-year prospective study 152
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 152
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 150
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 149
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis : Results From a Phase III Open-Label Study 149
Different histological classifications for Henoch-Schönlein purpura nephritis : which one should be used? 149
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment 147
Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets 145
Demethylation of the RORC2 and IL17A in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells 145
Recurrent Pericarditis in Children and Adolescents 145
Clinical and transcriptional response to the long‐acting interleukin‐1 blocker canakinumab in Blau syndrome–related uveitis 144
Etanercept inhibits the TNF-α driven shifting of Th17 towards non-classic Th1 phenotype in juvenile idiopathic arthritis 144
Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: Comment on the article by Costedoat-Chalumeau et al 143
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion 142
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug : Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis 141
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 139
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 139
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 139
Impact of in utero environment on the offspring of lupus patients 137
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy 136
Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases 136
SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association 135
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 134
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 134
Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic 134
Monogenic forms of systemic lupus erythematosus : new insights into SLE pathogenesis 134
Prevention of flare recurrences in childhood-refractory chronic uveitis : an open-label comparative study of adalimumab versus infliximab 131
Elicitation of expert prior opinion : application to the MYPAN trial in childhood polyarteritis nodosa 131
Hyaluronic Acid Injections in the Treatment of Osteoarthritis Secondary to Primary Inflammatory Rheumatic Diseases: A Systematic Review and Qualitative Synthesis 131
The Effect of Corrected Inflammation, Oxidative Stress and Endothelial Dysfunction on Fmd Levels in Patients with Selected Chronic Diseases : A Quasi-Experimental Study 131
Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center 130
Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome) 129
Extensive ethnic variation and linkage disequilibrium at the FCGR2/3 locus : different genetic associations revealed in Kawasaki disease 129
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 128
Kawasaki disease in Sicily : clinical description and markers of disease severity 128
Arthritis and infections 127
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 127
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation : a series of 158 cases from the Eurofever/EUROTRAPS international registry 126
Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism 126
Pediatric antiphospholipid syndrome : clinical and immunologic features of 121 patients in an international registry 125
QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block 125
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 125
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists : a Nationwide Multi-Center Retrospective Observational Study 125
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis 125
Should coronavirus disease 2019-associated inflammatory syndromes in children affect social reintegration? 125
Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block : lesson from twins and triplets discordant for the disease 124
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 122
The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis 121
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 121
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 120
Totale 22.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.097 0 0 0 0 0 773 309 601 413 321 355 325
2021/20224.073 248 245 228 222 296 190 233 332 383 438 317 941
2022/20234.387 640 285 307 366 309 983 214 263 398 147 280 195
2023/20244.390 217 332 262 332 704 405 232 321 190 285 515 595
2024/20258.864 346 1.170 293 750 654 548 652 881 544 581 836 1.609
2025/20267.348 1.179 930 1.934 1.651 1.528 126 0 0 0 0 0 0
Totale 43.232